En bloc re-resection of high-risk NMIBC after en bloc resection: results of a multicenter observational study.

Rodolfo HurlePaolo CasaleMassimo LazzeriMarco PaciottiAlberto SaitaPiergiuseppe ColomboEmanuela MorenghiDavid OswaldDaniela ColleselliMichael MitterbergerThomas KunitMartina HagerThomas R W HerrmannLukas Lusuardi

Published in: World journal of urology (2019)

The low rates of residual tumor, recurrence, and progression seem to raise doubts about the efficacy of EBRS in patients who have previously undergone en bloc resection. EBRS appears to be a feasible and safe procedure with a low rate of complications. However, further data will be needed before EBRS can be used in clinical trials or recommended as a treatment modality.

Keyphrases

clinical trial
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
risk factors
randomized controlled trial
machine learning
cross sectional
patient reported
open label